Compare Nuwellis Inc (NUWE) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Global X Uranium ETF — how do they compare? Nuwellis Inc trades at $1.42 (market cap $542.80K), while Global X Uranium ETF trades at $45.09. The key difference: Global X Uranium ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | URA | |
|---|---|---|
Market Cap | $542.80K | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $220.50 | $61.81 |
52-Week Low | $1.42 | $36.45 |
Enterprise Value | -$1.27M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.41, down 0.7% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with preliminary Q2 2026 revenue up 14% year-over-year, but remains unprofitable with a net income margin of -217.22%. Recent developments include a reverse stock split, new CEO appointment, and expansion of its Aquadex platform into new pediatric markets. Cash flow from operations is negative, though recent financing activities have provided capital.
The outlook is mixed: growth initiatives and analyst support offer potential, but persistent losses and high cash burn pose significant risks. Investors should weigh the company's expansion against its financial sustainability.
URA, the Global X Uranium ETF, trades at $45.34, up 2.16% today with a bullish technical signal from moving averages. The ETF benefits from strong nuclear energy tailwinds including $17.5 billion in federal funding and growing AI power demand. Recent index additions like Terra Innovatum and Eagle Nuclear Energy expand the fund's exposure to nuclear infrastructure companies.
The uranium sector faces near-term volatility but long-term structural growth drivers remain intact. Key risks include policy uncertainty and uranium price fluctuations, while opportunities stem from nuclear energy's role in meeting AI power demands and global decarbonization goals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
